Insiders · KRSA

Jonathan Violin

Officer, Director at Korsana Biosciences, Inc. (KRSA) since September 2026

Jonathan Violin has filed 28 insider reports with the SEC since January 2021, as officer and director at Korsana Biosciences, Inc. (KRSA), director at Crescent Biopharma, Inc. (CBIO) and director at Dianthus Therapeutics, Inc. /DE/ (DNTH) and at 3 more companies. Jonathan Violin made no open-market purchases or sales in the last 12 months. The latest filing, on September 10, 2026, is a Form 3: Jonathan Violin became an insider at Korsana Biosciences, Inc. (KRSA).

Filings
28
Companies
6
Bought on market
None
Sold on market
$6.11M

Companies where Jonathan Violin is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Korsana Biosciences, Inc. logo
KRSA
Korsana Biosciences, Inc.
Officer, Directorsince September 2026207,400$33.27Sep 10, 2026
Crescent Biopharma, Inc. logo
CBIO
Crescent Biopharma, Inc.
Directorsince June 202569,515$12.40Jun 3, 2026
Dianthus Therapeutics, Inc. /DE/ logo
DNTH
Dianthus Therapeutics, Inc. /DE/
Directorsince September 2023$83.98May 22, 2026
Astria Therapeutics, Inc. logo
ATXS
Astria Therapeutics, Inc.
Director0Jan 23, 2026
Viridian Therapeutics, Inc.\DE logo
VRDN
Viridian Therapeutics, Inc.\DE
Officer, Director480,905$6.11M$30.12Feb 7, 2023
Astria Therapeutics, Inc. logo
CATB
Astria Therapeutics, Inc.
Directorsince January 2021263,321Sep 22, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Jonathan Violin.

Compare Jonathan Violin with

Other insiders at the same companies

Questions about Jonathan Violin

What is Jonathan Violin's role at Korsana Biosciences, Inc.?
Jonathan Violin reports to the SEC as officer and director at Korsana Biosciences, Inc. (KRSA), according to the latest filing on September 10, 2026. Jonathan Violin has also filed as director at Crescent Biopharma, Inc. (CBIO), director at Dianthus Therapeutics, Inc. /DE/ (DNTH), director at Astria Therapeutics, Inc. (ATXS) and officer and director at Viridian Therapeutics, Inc.\DE (VRDN).
How many shares does Jonathan Violin own?
After the latest filing that states it, Jonathan Violin directly owned 207,400 shares of Korsana Biosciences, Inc. (KRSA), 69,515 shares of Crescent Biopharma, Inc. (CBIO), 480,905 shares of Viridian Therapeutics, Inc.\DE (VRDN) and 263,321 shares of Astria Therapeutics, Inc. (CATB). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jonathan Violin bought or sold stock recently?
The most recent open-market sale was on February 2, 2023: sold 50,000 shares of Viridian Therapeutics, Inc.\DE (VRDN) for $1.84M at an average of $36.80.
How do I get alerts when Jonathan Violin files?
Follow Jonathan Violin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Jonathan Violin filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Jonathan Violin (SEC CIK 0001730615). Totals count each trade once, skipping amendments whose original is on file, from Jan 20, 2021 on. View on SEC EDGAR